All the participants of the ACCORD 2022 Conference are offered an additional opportunity to publish a conference paper in a Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 2.0” of the International Journal of Molecular Sciences (IJMS, ISSN 1422-0067; CODEN: IJMCFK; ISSN 1661-6596 for the printed edition, https://www.mdpi.com/journal/ijms).
IJMS is an international peer-reviewed open access journal providing an advanced forum for biochemistry, molecular and cell biology, molecular biophysics, molecular medicine, and all aspects of molecular research, and is published semi-monthly online by the Multidisciplinary Digital Publishing Institute (MDPI), Basel, Switzerland.
The conference paper will publicize well the research presented and discussed at our Conference as an invited lecture, short oral presentation, or poster (printed poster or spotlight poster presentation).
Manuscripts from ACCORD 2022 Conference are welcome from all the disciplines of drug sciences, starting from drug design and molecular modeling, molecular target identification, leads generation and optimization, through medicinal and analytical chemistry, drug carriers and dosage forms development, in silico, in vitro, ex vivo, and in vivo evaluations, to preclinical and clinical trials. Manuscripts from other fields related to the drug development process are also invited.
The manuscripts will undergo regular peer review before being published online. Information for authors, containing links to useful resources and instructions are available on the journal website https://www.mdpi.com/authors.
The good news is the Scientific
Committee has just been granted by the Publisher a special discount of 30% from the regular Article Processing Charge
for the papers published by all the Conference attendees in a Special Issue “Novel Strategies in
the Development of New Therapies, Drug Substances and Drug Carriers 2.0” of the International Journal of Molecular Sciences.
Participants will also have an opportunity to publish their research presented at the Conference in the regular issue of Acta Poloniae Pharmaceutica – Drug Research. The journal currently has 100 points of the Ministry of Science and Higher Education. The Open Access fee depends on the number of manuscripts submitted by the Conference participants. When 20 manuscripts are published, the fee for the manuscript is PLN 3,240 (approx. EUR 720, including VAT), and for more than 20 manuscripts, the fee for the manuscript is PLN 2,160 (approx. EUR 480, including VAT). It is recommended to include in the manuscript the footnote at the front page “Presented in part at the ACCORD 2022 Conference, Warsaw, Poland, May 26-28, 2022. The deadline for submission of the manuscripts is June 30, 2022. The manuscripts will be reviewed by September 30, 2022, and published in Vol. 79 No.6, 2022. The detailed info about the journal can be found on the website.